USA - NYSE:HRC - Common Stock
The current stock price of HRC is 155.96 null. In the past month the price increased by 0.55%. In the past year, price increased by 62.29%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 26.17 | 227.29B | ||
| ISRG | INTUITIVE SURGICAL INC | 63.82 | 196.99B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.81 | 152.16B | ||
| SYK | STRYKER CORP | 27.5 | 138.48B | ||
| BDX | BECTON DICKINSON AND CO | 13.39 | 55.33B | ||
| IDXX | IDEXX LABORATORIES INC | 54.71 | 55.19B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.58 | 50.67B | ||
| RMD | RESMED INC | 24.69 | 35.68B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.94 | 33.40B | ||
| PODD | INSULET CORP | 72.8 | 23.42B | ||
| DXCM | DEXCOM INC | 31.22 | 22.77B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.11 | 17.81B |
Hill-Rom Holdings, Inc. operates as a medical technology company. The company is headquartered in Chicago, Illinois and currently employs 10,000 full-time employees. The firm's segments include Patient Support Systems, Front Line Care and Surgical Solutions. Patient Support Systems provides an ecosystem of digital and connected care solutions: devices, software, communications and integration technologies that improve care and deliver insights to caregivers and patients in the acute care setting. Front Line Care provides integrated patient monitoring and diagnostic technologies from hospital to home that enable and support its connected care strategy. Surgical Solutions enables peak procedural performance, connectivity and video integration products that improve collaboration, workflow, safety and efficiency in the operating room, such as surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. The firm also owns contact-free continuous monitoring technology.
Hill Rom Holdings
130 E Randolph St Ste 1000
Chicago ILLINOIS 60601 US
CEO: John P. Groetelaars
Employees: 10000
Phone: 13128197200.0
Hill-Rom Holdings, Inc. operates as a medical technology company. The company is headquartered in Chicago, Illinois and currently employs 10,000 full-time employees. The firm's segments include Patient Support Systems, Front Line Care and Surgical Solutions. Patient Support Systems provides an ecosystem of digital and connected care solutions: devices, software, communications and integration technologies that improve care and deliver insights to caregivers and patients in the acute care setting. Front Line Care provides integrated patient monitoring and diagnostic technologies from hospital to home that enable and support its connected care strategy. Surgical Solutions enables peak procedural performance, connectivity and video integration products that improve collaboration, workflow, safety and efficiency in the operating room, such as surgical video technologies, tables, lights, pendants, precision positioning devices and other accessories. The firm also owns contact-free continuous monitoring technology.
The current stock price of HRC is 155.96 null. The price increased by 0.03% in the last trading session.
Hill Rom Holdings (HRC) has a dividend yield of 0.62%. The yearly dividend amount is currently 0.94.
HRC has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
HRC stock is listed on the New York Stock Exchange, Inc. exchange.
Hill Rom Holdings (HRC) currently has 10000 employees.
Hill Rom Holdings (HRC) will report earnings on 2022-02-15, before the market open.
ChartMill assigns a technical rating of 9 / 10 to HRC. When comparing the yearly performance of all stocks, HRC is one of the better performing stocks in the market, outperforming 91.11% of all stocks.
ChartMill assigns a fundamental rating of 5 / 10 to HRC. Both the profitability and the financial health of HRC get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months HRC reported a non-GAAP Earnings per Share(EPS) of 6.31. The EPS increased by 14.1% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 8.23% | ||
| ROA | 4.97% | ||
| ROE | 13.22% | ||
| Debt/Equity | 0.97 |
14 analysts have analysed HRC and the average price target is 159.12 null. This implies a price increase of 2.03% is expected in the next year compared to the current price of 155.96.
For the next year, analysts expect an EPS growth of 3.85% and a revenue growth 3.75% for HRC